A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.

scientific article

A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10850424

P50authorJames F. GusellaQ1602688
Antoni CastellsQ37839005
P2093author name stringRamesh V
Rustgi AK
P433issue11
P407language of work or nameEnglishQ1860
P304page(s)2836-2839
P577publication date2000-06-01
P1433published inCancer ResearchQ326097
P1476titleA region of deletion on chromosome 22q13 is common to human breast and colorectal cancers
P478volume60

Reverse relations

cites work (P2860)
Q33867526Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma
Q41432640BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma
Q37524058CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations
Q36545056CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.
Q36696688Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation
Q41536811Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors
Q35011398Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer
Q34253712Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract
Q36859140Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Q38649909Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes.
Q34762457Individuality and variation in gene expression patterns in human blood
Q36047387Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
Q30396926Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma
Q37589094PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Q36421428Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation
Q30476046Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions
Q37678053Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
Q34388828Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.
Q37039595Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
Q36386270ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines
Q30657925THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data
Q37065730Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters
Q38000062The bisecting GlcNAc in cell growth control and tumor progression
Q36325617The parvins
Q33910850Type II transmembrane serine protease gene variants associate with breast cancer
Q35663665What we know about ST13, a co-factor of heat shock protein, or a tumor suppressor?

Search more.